1. Home
  2. DRCT vs AZTR Comparison

DRCT vs AZTR Comparison

Compare DRCT & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$0.57

Market Cap

1.8M

Sector

Technology

ML Signal

HOLD

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.23

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRCT
AZTR
Founded
2018
2014
Country
United States
United States
Employees
73
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.9M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
DRCT
AZTR
Price
$0.57
$0.23
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$8.00
$4.00
AVG Volume (30 Days)
79.8K
21.5M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.06
EPS
N/A
N/A
Revenue
$34,694,000.00
N/A
Revenue This Year
$58.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.10
52 Week High
$6.04
$1.40

Technical Indicators

Market Signals
Indicator
DRCT
AZTR
Relative Strength Index (RSI) 29.44 51.35
Support Level $0.34 $0.22
Resistance Level $0.61 $0.23
Average True Range (ATR) 0.09 0.03
MACD 0.00 -0.00
Stochastic Oscillator 12.54 15.05

Price Performance

Historical Comparison
DRCT
AZTR

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: